PureTech Health plc (NASDAQ:PRTC) Q2 2024 Earnings Conference Call August 28, 2024 9:00 AM ET

Company Participants

Allison Mead Talbot - Head of Communications
Bharatt Chowrira - CEO
Eric Elenko - Co-Founder & President

Conference Call Participants

Lucy Codrington - Jefferies
Thomas Smith - Leerink Partners
Miles Dixon - Peel Hunt

Operator

Greetings, and welcome to the PureTech Health 2024 Half Year Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-and-answer session, and instructions will follow at that time. As a reminder, this conference is being recorded.

It is now my pleasure to introduce your host, Allison Mead Talbot, Head of Communications. Thank you, Allison, you may begin.

Allison Mead Talbot

Thank you for joining us today for PureTech's 2024 half year results webcast. Our half year report was made available this morning and was also filed with the SEC. This information is available on the Investors page of our website at puretechhealth.com.

PureTech is led by a proven and seasoned management team with significant experience in discovering and developing important new medicines, delivering them to market and maximizing shareholder value. Today, I'm pleased to be joined by members of the senior team, including Bharatt Chowrira, Chief Executive Officer; Eric Elenko, Co-Founder and President; Robert Lyne, Chief Portfolio Officer; and Chip Sherwood, General Counsel.

I would like to remind you that during today's call, we will be making certain forward-looking statements. These statements are subject to various important risks, uncertainties and assumptions that could cause our actual results to differ materially from our expectations, and we ask that you refer to our annual report and our SEC filings for a complete discussion of these factors. You should not put undue reliance on any forward-looking statements. These forward-looking statements reflect our expectations as of the date of this call, and we take no obligation to revise or update any forward-looking statements or information, except as required by law.

I also want to remind you that we will be referring to certain non-IFRS measures in this presentation. The presentation of this non-IFRS financial information is not intended to be considered in isolation or as a substitute for financial information presented in accordance with IFRS. A reconciliation of IFRS to non-IFRS measures that we will be referring to today can be found in the accompanying presentation and is also available on our Investor Relations website at investors.puretechhealth.com and in our SEC filings.